03/31/2021
RICHLAND, WASHINGTON – March 31, 2021 – A recently published small prospective series of patients with recurrent ...
03/03/2021
RICHLAND, WASHINGTON – March 3, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed ...
02/16/2021
RICHLAND, WASHINGTON – February 16, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed
02/09/2021
Revenue Increased 7% Year-Over-Year
Non-Prostate Brachytherapy Revenue Increased 92% ...
02/05/2021
Conference Call is Tuesday, February 9, 2021 at 4:30 p.m. ET/1:30 p.m. PT
RICHLAND, WASHINGTON – February 5, 2021–
02/04/2021
RICHLAND, Wash., February 4, 2021 - Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator ...
02/03/2021
RICHLAND, Wash., February 3, 2021 - Isoray, Inc. (NYSE AMERICAN: ISR) (“Isoray” or the “Company”), a medical ...
01/07/2021
RICHLAND, WASHINGTON – January 7, 2021 – Isoray, Inc. (NYSE American: ISR), a medical technology company and seed ...
01/06/2021
HOUSTON, TEXAS - January 05, 2021 – C4 Imaging LLC is pleased to announce that Isoray Medical, Inc. (NYSE American:
11/24/2020
Studies Demonstrate Impact of Proprietary Isotope on Prostate and Brain Cancers At World’s Premier Radiation ...
11/10/2020
Revenue Increased 3% Year-Over-Year
Non-Prostate Brachytherapy Revenue Increased 104% Year-Over-Year
RICHLAND, ...
11/02/2020
Conference Call is Tuesday, November 10, 2020 at 4:30 p.m. ET/1:30 p.m. P
RICHLAND, WASHINGTON – November 2, ...
Media & Public Relations Contact
If you have questions or need help, please contact Sharon Schultz:
Sharon Schultz
Public and Media Relations